Company intelligence / Profile preview

Catalys Pacific

Minato-ku, Tokyo, Japan

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Catalys Pacific is a life sciences venture capital firm focused on creating and investing in bespoke biotech companies through transpacific partnerships, targeting areas such as hypertension, renal disease, CNS, liver disease, and oncology through its portfolio[1][2][3][4][5].

Therapeutic areas: EndocrinologyNephrologyGastroenterologyCardiovascularOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyNasal spray
Industry: Investors

Partnerships

Engages in partnerships via its portfolio companies; example: D2G Oncology (for Kirilys Therapeutics)

Beyond the preview

Go deeper on Catalys Pacific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catalys Pacific.

Explore the full profile